DEFA14A: BlackRock Defends Health Sciences Term Trust Against Saba Capital's Proxy Fight

BlackRock urges shareholders to vote against Saba Capital's proposal to terminate BlackRock's investment management agreement for the Health Sciences Term Trust (BMEZ).

Summary

• BlackRock is actively defending its Health Sciences Term Trust (BMEZ) against a proxy fight initiated by Saba Capital Management.
• Saba is attempting to oust BlackRock as the investment manager.
• BlackRock highlights actions taken to narrow discounts and enhance distributions across its closed-end funds.
• The document urges shareholders to vote FOR BlackRock's board nominees and AGAINST Saba's proposal.
• Shareholders are instructed to use the WHITE proxy card provided by BlackRock and disregard any GOLD cards received from Saba.
• BlackRock emphasizes the importance of preserving the fund and saving shareholder income.
• The document provides instructions on how to vote online, by phone, or by mail using the WHITE proxy card.
• BlackRock states that voting on the WHITE proxy card will replace any previously completed proxy cards from Saba.
• Georgeson LLC is available to answer shareholder questions at 1-866-529-4033.
• The document includes performance data showing discount narrowing for several BlackRock funds between December 31, 2022, and May 20, 2024.
• BMEZ discount narrowing improved by 28.62% from 17.75% to 12.67%.

Sentiment

Score: 7

Explanation: The document conveys a defensive but confident tone, highlighting past performance and urging shareholders to support BlackRock's management. The sentiment is moderately positive, reflecting BlackRock's efforts to maintain control and deliver value.

Positives

• BlackRock has taken actions to narrow discounts and enhance distributions across its closed-end funds.
• The document highlights discount narrowing across several BlackRock funds, including a 28.62% improvement for BMEZ from December 31, 2022, to May 20, 2024.
• BlackRock is actively fighting to defend shareholder interests against Saba Capital's proposal.

Negatives

• Saba Capital Management is attempting to oust BlackRock as the investment manager of the Health Sciences Term Trust (BMEZ).
• The proxy fight introduces uncertainty and potential disruption to the fund's management.

Risks

• The outcome of the proxy vote could lead to changes in the fund's management and investment strategy.
• Saba Capital's involvement could introduce different investment objectives or strategies that may not align with all shareholders' preferences.
• The proxy fight itself could create short-term market volatility for the fund.

Future Outlook

The document does not provide specific forward-looking statements beyond urging shareholders to vote in favor of BlackRock's nominees and against Saba's proposal.

Management Comments

• BlackRock has taken shareholder-friendly actions across its closed-end funds to narrow discounts, enhance distributions and deliver long-term value.
• BlackRock is fighting for YOU.

Industry Context

Activist investors like Saba Capital often target closed-end funds trading at a discount to NAV, seeking to unlock value through various strategies, including replacing the investment manager or forcing a liquidation. This proxy fight is part of a broader trend of increased activism in the closed-end fund space.

Comparison to Industry Standards

• The document compares the performance of BMEZ and other BlackRock funds to relevant benchmark indexes, such as the MSCI Custom ACWI SMID Growth HC Call Overwrite Index for BMEZ.
• The discount narrowing achieved by BMEZ (28.62%) is presented as a positive outcome compared to its own historical performance.
• It's difficult to assess the discount narrowing against industry standards without knowing the specific strategies and market conditions affecting comparable health sciences closed-end funds managed by firms like Tekla Capital Management or Allianz Global Investors.

Stakeholder Impact

• Shareholders are directly impacted by the outcome of the proxy vote, which will determine the fund's management and investment strategy.
• BlackRock's reputation and future management of other closed-end funds could be affected by the outcome.
• Saba Capital's success or failure in this proxy fight could influence its future activist campaigns.

Next Steps

• Shareholders need to vote on the proxy proposals.
• The outcome of the vote will determine the future management of the Health Sciences Term Trust (BMEZ).

Key Dates

Keywords

BlackRock, Saba Capital, BMEZ, Health Sciences Term Trust, Proxy Fight, Investment Management, Closed-End Fund, Discount Narrowing, Shareholder Value, Proxy Vote